NM_032806.6:c.377A>G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032806.6(POMGNT2):c.377A>G(p.Asn126Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000384 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032806.6 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- myopathy caused by variation in POMGNT2Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032806.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| POMGNT2 | NM_032806.6 | MANE Select | c.377A>G | p.Asn126Ser | missense | Exon 2 of 2 | NP_116195.2 | ||
| POMGNT2 | NM_001437285.1 | c.377A>G | p.Asn126Ser | missense | Exon 3 of 3 | NP_001424214.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| POMGNT2 | ENST00000344697.3 | TSL:1 MANE Select | c.377A>G | p.Asn126Ser | missense | Exon 2 of 2 | ENSP00000344125.2 | ||
| POMGNT2 | ENST00000441964.1 | TSL:4 | c.377A>G | p.Asn126Ser | missense | Exon 3 of 3 | ENSP00000408992.1 | ||
| POMGNT2 | ENST00000686643.1 | c.377A>G | p.Asn126Ser | missense | Exon 4 of 4 | ENSP00000509123.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152112Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251448 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461890Hom.: 0 Cov.: 37 AF XY: 0.0000509 AC XY: 37AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152112Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74320 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.377A>G (p.N126S) alteration is located in exon 2 (coding exon 1) of the POMGNT2 gene. This alteration results from a A to G substitution at nucleotide position 377, causing the asparagine (N) at amino acid position 126 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 126 of the POMGNT2 protein (p.Asn126Ser). This variant is present in population databases (rs750654109, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with POMGNT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 540489). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POMGNT2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8;C4748320:Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 Other:1
Variant classified as Uncertain significance and reported on 10-01-2020 by Invitae. GenomeConnect-InvitaePIN assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at